- 1. (-)-Cholesterol
- [C27H46O, the major fatty steroid alcohol of vertebrate animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. ( CSP )] (UMLS (NCI) C0008377) =Steroid; Biologically Active Substance ;
=cholestane compound;
Cholestenes;
sterol;
Unclassified Ingredient Preparations =hydroxycholesterol;
cholesterol oxide;
SALICYLIC ACID 40% OINTMENT(GM);
BASLE CREAM,TOP;
ALUMINUM ACETATE/ZINC OXIDE PASTE,TOP;
CHOLESTEROL 3 %;
| - 51. CHOLESTERIN GRANULOMA
- (UMLS (ICD9CM) C0155492) =Disease or Syndrome ;
|
- 2. CH OB ASTHMA W STAT ASTH
- [ ] (UMLS (ICD9CM) C0375334) =Disease or Syndrome ;
| - 52. Cholesterol 20-22 Desmolase
- [Encoded by human CYP11A1 Gene (Cytochrome P450 Family), 521-aa 60-kDa (precursor) Cytochrome P450C11A1 is a mitochondrial inner membrane P450 heme-thiolate monooxygenase that catalyzes a side-chain cleavage reaction conversion of cholesterol to pregnenolone, the first (rate-limiting) step in the synthesis of steroid hormones. CYP11A1 defects cause congenital adrenal insufficiency (CAI) and congenital lipoid adrenal hyperplasia (CLAH). P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0008381) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 3. CH OBST ASTH W (AC) EXAC
- (UMLS (ICD9CM) C1176341) Chronic obstructive asthma, with acute exacerbation =Disease or Syndrome ;
| - 53. Cholesterol 7 Alpha-Monooxygenase
- [Encoded by human CYP7A1 Gene (Cytochrome P450 Family), 504-aa 58-kDa Cytochrome P450 7A1 is an endoplasmic reticulum membrane-bound P450 heme-thiolate monooxygenase in the liver that catalyzes the first (rate-limiting) reaction in the cholesterol catabolic pathway: cholesterol conversion to bile acids, the major site of regulation of bile acid synthesis and the primary mechanism for removal of cholesterol from the body. P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0008396) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4. CHOANAL ATRESIA
- [Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture. ( MSH )] (UMLS (ICD9CM) C0008297) =Congenital Abnormality =nasal disorder;
Aangeboren afwijkingen luchtwegen | - 54. cholesterol analog
- [synthetic or natural chemical compounds which resemble cholesterols in structure and/or function. ( CSP )] (UMLS (CSP) C0596331) =Steroid ;
=steroid analog;
|
- 5. Choanichthyes
- [ ] (UMLS (CSP) C0599048) =Fish
| - 55. cholesterol biosynthesis
- [The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. [GOC:ai] ( GO )] (UMLS (CSP) C0599474) =Molecular Function
|
- 6. Choctaw
- (UMLS (HL7) C0574569) =Language =WesternMuskogean;
◊ (UMLS (HL7) C0682100) Population Group American Indian; Clifton Choctaw; Jena Choctaw; Mississippi Choctaw; Mowa Band of Choctaw; Oklahoma Choctaw | - 56. cholesterol ester
- [fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in human plasma; accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. ( CSP )] (UMLS (CSP) C0008387) =Steroid; Biologically Active Substance ;
=sterol ester;
|
- 7. Choctaw Nation of Oklahoma
- (UMLS (HL7) C1554265) =Population Group =NativeEntityContiguous;
| - 57. cholesterol ester storage disease
- [rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase; results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells); it is an allelic variant of Wolman disease. ( CSP )] (UMLS (CSP) C0008384) =Disease or Syndrome =inborn lipid storage disorder;
inborn lysosomal enzyme disorder |
- 8. CHOD
- (UMLS (NCI) C0082139) =Therapeutic or Preventive Procedure
| - 58. cholesterol esterase
- [acts on esters of sterols and long chain fatty acids may bring about esterification of sterols activated by bile salts. ( CSP )] (UMLS (CSP) C0008385) =Amino Acid, Peptide, or Protein; Enzyme ;
=carboxylesterase;
|
- 9. choice
- [act of making a selection among two or more alternatives, usually after a period of deliberation. ( CSP )] (UMLS (CSP) C0008300) =Individual Behavior =decision making;
| - 59. Cholesterol Granuloma
- (UMLS (NCI) C0333411) =Pathologic Function
|
- 10. Choking
- [A condition caused by blocking the airways to the lungs and interference with the respiration by compression or obstruction of the larynx or trachea. ( NCI )] (UMLS (NCI) C0008301) =Finding
| - 60. Cholesterol Homeostasis
- [Any of the processes involved in the maintenance of an internal equilibrium of cholesterol within an organism or cell. (Gene Ontology) ( NCI )] (UMLS (NCI) C1326960) =Physiologic Function
|
- 11. CHOL
- [A measurement of the cholesterol in a biological specimen. ( NCI )] (UMLS (NCI) C1445957) Cholesterol;
Serum Total Cholesterol Measurement =Laboratory Procedure ;
| - 61. cholesterol oxide
- [ ] (UMLS (CSP) C0596332) =Steroid ;
=(-)-Cholesterol;
|
- 12. cholagogue
- [ ] (UMLS (CSP) C0008303) =Pharmacologic Substance
| - 62. Cholesterol Screening
- (UMLS (HL7) C1548835) =Health Care Activity =Consent Type;
|
- 13. cholanate compound
- [steroid bile acids and salts; primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine, secondary bile acids are further modified by bacteria in the intestine; cholanate compounds play an important role in the digestion and absorption of fat. ( CSP )] (UMLS (CSP) C0178549) =Steroid; Biologically Active Substance =Steroid;
=chenodeoxycholate;
cholate;
ursodeoxycholate;
| - 63. Cholesterolosis of gallbladder
- [ ] (UMLS (ICD9CM) C0152456) =Disease or Syndrome
|
- 14. Cholangiocarcinoma
- [(ko-LAN-jee-o-sar-KO-ma) A tumor of the connective tissues of the bile ducts. ( NCI )] (UMLS (NCI) C0206698) =Neoplastic Process =adenocarcinoma;
| - 64. cholestyramine
- [strongly basic anion exchange resin used to extract bile salts and cholesterol, to treat diarrhea and biliary obstruction, and as an antipruritic. ( CSP )] (UMLS (CSP) C0008402) =Organic Chemical; Pharmacologic Substance ;
=antihypercholesterolemic agent;
[CV350] ANTILIPEMIC AGENTS;
polystyrene;
quaternary ammonium compound =CHOLESTYRAMINE 4 GM;
CHOLESTYRAMINE 4 GM/5GM;
CHOLESTYRAMINE 4 GM/9GM |
- 15. CHOLANGIOGRAM NEC
- [ ] (UMLS (ICD9CM) C0029538) =Diagnostic Procedure ;
| - 65. choline
- [essential nutrient that is part of the B-complex family of vitamins and is a constituent of lecithin; it is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism; it also aids in hormone production and is needed for the proper transmission of nerve impulses, liver function and gallbladder regulation. ( CSP )] (UMLS (CSP) C0008405) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =ammonium compound;
Betaine;
Ethanolamines;
[TN900] THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES, OTHER =acetylcholine;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
METHACHOLINE;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
CHOLINE (AS BITARTRATE);
CHOLINE CHLORIDE;
SUCCINYLCHOLINE;
choline salicylate;
Choline, hydroxide, compound with Theophylline(1:1);
CHOLINE (AS BITARTRATE);
CHOLINE CHLORIDE;
Lecithin 420 MG Oral Capsule;
MAGNACAL NUTRITIONAL SUPPLEMENT LIQUID;
NURSOY LIQUID;
S-M-A IRON FORTIFIED,INFANT FORMULA CONC,ORAL;
S-M-A IRON FORTIFIED,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA CONC,ORAL;
S-M-A LO-IRON,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA PWDR;
S-M-A IRON FORTIFIED,INFANT FORMULA PWDR;
CHOLINE 25 MG;
CHOLINE 300 MG;
CHOLINE 500 MG;
TRAUM-AID HBC PWDR (LEMONCREME);
CHOLINE 100 MG;
CHOLINE 100 MG/240ML;
CHOLINE 100 MG/30ML;
CHOLINE 102 MG/240ML;
CHOLINE 107 MG;
CHOLINE 107 MG/240ML;
CHOLINE 111 MG;
CHOLINE 114 MG/240ML;
CHOLINE 118 MG/240ML;
CHOLINE 125 MG/240ML;
CHOLINE 150 MG/240ML;
CHOLINE 16.7 MG/5ML;
CHOLINE 452 MG/L;
CHOLINE 454 MCG/ML;
CHOLINE 520 MG/L;
CHOLINE 530 MG/L;
CHOLINE 71 MG/240ML;
CHOLINE 75 MG;
CHOLINE 75 MG/240ML |
- 16. cholangiography
- [radiographic examination of the bile ducts after injection with a contrast medium. ( CSP )] (UMLS (CSP) C0008307) =Diagnostic Procedure =biliary tract imaging/visualization;
| - 66. choline acetylase
- [An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. ( MSH )] (UMLS (CSP) C0008407) =Amino Acid, Peptide, or Protein; Enzyme ;
=Acetyltransferase;
|
- 17. cholangiole
- [ ] (UMLS (CSP) C0227516) =Body Part, Organ, or Organ Component
| - 67. choline analog
- [ ] (UMLS (CSP) C0597837) =Organic Chemical; Biologically Active Substance ;
|
- 18. cholangitis
- [Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. ( MSH )] (UMLS (CSP) C0008311) =Disease or Syndrome =Bile Duct Diseases;
=Cholangitis, Sclerosing | - 68. choline deficiency
- [state in which choline is absent or in diminished amount relative to the normal requirement of an organism or a biologic system. ( CSP )] (UMLS (CSP) C0008412) =Disease or Syndrome =Deficiency of B-complex components;
|
- 19. cholate
- [major primary bile acid, its salts and esters; produced in the liver and usually conjugated with glycine or taurine; facilitates fat absorption and cholesterol excretion. ( CSP )] (UMLS (CSP) C0109497) =Steroid; Pharmacologic Substance; Biologically Active Substance =cholanate compound;
=choleate | - 69. choline esterase II
- [enzyme of the hydrolase class that catalyzes the cleavage of the acyl group from various esters of choline, including acetylcholine, and some related compounds the enzyme occurs primarily in the serum, liver, and pancreas determination of enzyme activity is used to test liver function, succinylcholine sensitivity, and whether organophosphate insecticide poisoning has occurred. ( CSP )] (UMLS (CSP) C0008429) =Amino Acid, Peptide, or Protein; Enzyme ;
=Ester Hydrolase;
carboxylesterase =Succinylcholinesterase |
- 20. choleate
- [bile acid formed by bacterial action from cholate; usually conjugated with glycine or taurine; deoxycholate acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. ( CSP )] (UMLS (CSP) C0086123) =Steroid; Pharmacologic Substance; Biologically Active Substance =cholate;
| - 70. choline inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of choline. ( CSP )] (UMLS (CSP) C0596333) =Pharmacologic Substance ;
=inhibitor/antagonist;
|
- 21. cholecystectomy
- [surgical removal of the gallbladder. ( CSP )] (UMLS (CSP) C0008320) =Therapeutic or Preventive Procedure ;
=biliary tract surgery;
| - 71. choline phosphatase
- [ ] (UMLS (CSP) C0070943) =Amino Acid, Peptide, or Protein; Enzyme
|
- 22. cholecystitis
- [inflammation of the gallbladder; generally caused by impairment of bile flow, gallstones in the biliary tract, infections, or other diseases. ( CSP )] (UMLS (CSP) C0008325) =Disease or Syndrome ;
=Unspecified disorder of gallbladder;
| - 72. Choline, hydroxide, compound with Theophylline(1:1)
- [The choline salt of theophylline with an anti-asthmatic property. Oxtriphylline appears to inhibit phosphodiesterase and prostaglandin production, regulates calcium flux and intracellular calcium distribution, and antagonizes adenosine. Physiologically, this agent causes relaxation of bronchial smooth muscle, produces vasodilation (except in cerebral vessels), stimulates cardiac muscle, as well as induces diuresis and gastric acid secretion. It may also suppress inflammation and improve contractility of the diaphragm. ( NCI )] (UMLS (NCI) C0055578) =Organic Chemical; Pharmacologic Substance =choline;
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione;
[RE104] BRONCHODILATORS, XANTHINE-DERIVATIVE;
=cholinophyllin 10 MG/ML;
cholinophyllin 20 MG/ML;
cholinophyllin 200 MG;
cholinophyllin 400 MG;
cholinophyllin 600 MG;
OXTRIPHYLLINE 100 MG;
|
- 23. Cholecystitis/cholelithiasis
- (UMLS (ICPC) C0267853) (Cholecystitis/cholelithiasis; KOLEZISTITISA/KOLELITIASISA; Galdesten/galdeblaerebetaendelse; Cholecystitis/cholelithiasis; SAPPIRAKON TULEHDUS/ SAPPIKIVET; Cholecystite/cholelithiase; Cholezystitis/Cholelithiasis; xoletzistitis o avanim; cholecystitis/cholelithiasis; Colecistite/colelitiasi; GALLESTEN/GALLEVEISBETENNELSE - k80 - k81 - k82 - k83 - k87; Colecistite/colelitiase; Colecistitis/colelitiasis; INFLAMMATION I GALLBLASA/GALLSTEN) =Disease or Syndrome =Body System, Gastrointestinal; Diagnosis/Diseases Component
| - 73. cholinergic
- [ ] (UMLS (CSP) C0599668) =Functional Concept
|
- 24. cholecystolithiasis
- [Presence or formation of GALLSTONES in the GALLBLADDER. ( MSH )] (UMLS (CSP) C0947622) Gallbladder Calculus;
Gallbladder Stone =Disease or Syndrome | - 74. cholinergic agent
- [drug used for its actions in stimulating cholinergic systems. ( CSP )] (UMLS (CSP) C0242893) =Pharmacologic Substance ;
=neuropharmacologic agent;
=acetylcholine;
arecoline;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
muscarine;
neostigmine;
(-)-Nicotine;
PHYSOSTIGMINE;
PILOCARPINE;
PYRIDOSTIGMINE;
METHACHOLINE;
|
- 25. CHOLECYSTOSTOMY NEC
- [ ] (UMLS (ICD9CM) C0029540) =Therapeutic or Preventive Procedure ;
| - 75. Cholinergic Agonist
- [A class of agents that interact with cholinergic receptors, i.e., nicotinic and muscarinic receptors. ( NCI )] (UMLS (NCI) C0242894) =Pharmacologic Substance ;
|
- 26. Cholecystotomy and cholecystostomy
- [ ] (UMLS (ICD9CM) C0176891) =Therapeutic or Preventive Procedure
| - 76. cholinergic blocking agent
- [Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. ( MSH )] (UMLS (CSP) C0242897) =Pharmacologic Substance ;
|
- 27. CHOLECYSTOTOMY NEC
- [ ] (UMLS (ICD9CM) C0176894) =Therapeutic or Preventive Procedure
| - 77. Cholinergic Differentiation Factor
- [Leukemia Inhibitory Factor (LIF) affects many systems, including hematopoietic, embryonic, bone, hepatic, neuronal, and fat tissues. LIF induces MHC class I HLA-G expression by cytotrophoblasts, which is essential in implantation and may facilitate immune tolerance of the conceptus at the maternal-fetal interface. LIF, secreted by ureteric bud cells, converts kidney mesenchyme to epithelia, which then forms nephrons. LIF and BMP2 cytokines signal through different receptors and transcription factors (STATs and SMADs) and act in synergy on neural progenitors to induce astrocytes. Transcriptional co-activator p300 interacts with STAT3 in a cytokine-independent manner and with SMAD1 in a cytokine-dependent manner. Formation of a STAT3/SMAD1 complex, bridged by p300, mediates cooperative signaling of LIF and BMP2 and induction of astrocytes from neuronal progenitors. (from OMIM and NCI) ( NCI )] (UMLS (NCI) C1453955) D Factor;
D-Factor;
Differentiation Stimulating Factor;
Differentiation-Stimulating Factor;
Human Interleukin in DA Cells;
Leukemia Inhibitory Factor;
Leukemia-Inhibitory Factor;
LIF;
Melanoma-Derived LPL Inhibitor;
MLPLI =Amino Acid, Peptide, or Protein; Immunologic Factor |
- 28. Choledochal Cyst
- [A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common. ( MSH )] (UMLS (NCI) C0008340) =Congenital Abnormality; Disease or Syndrome =Common Bile Duct Diseases;
cyst | - 78. cholinergic nerve differentiation factor
- [ ] (UMLS (CSP) C0598770) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 29. CHOLEDOCHOENTEROSTOMY
- [ ] (UMLS (ICD9CM) C0193558) =Therapeutic or Preventive Procedure
| - 79. cholinergic neuronal differentiation factor
- [ ] (UMLS (CSP) C0068611) =Amino Acid, Peptide, or Protein; Hormone
|
- 30. CHOLEDOCHOHEPAT INTUBAT
- (UMLS (ICD9CM) C0193491) =Therapeutic or Preventive Procedure
| - 80. cholinergic receptor
- [since the 2 subtypes are distinctly different receptors, use MUSCARINIC or NICOTINIC whenever possible; use this general term only for unspecified binding of acetylcholine and related ligands. ( CSP )] (UMLS (CSP) C0034792) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
=muscarinic receptor;
nicotinic receptor;
|
- 31. choledocholithiasis
- [Presence or formation of GALLSTONES in the COMMON BILE DUCT. ( MSH )] (UMLS (CSP) C0701818) =Disease or Syndrome
| - 81. Cholinergic Receptor, Muscarinic 1
- [The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The muscarinic cholinergic receptor 1 is involved in mediation of vagally-induced bronchoconstriction and in the acid secretion of the gastrointestinal tract. The gene encoding this receptor is localized to 11q13, with MDU1 proximally and COX8 distally located. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1318050) CHRM1;
Muscarinic Acetylcholine Receptor M1 =Amino Acid, Peptide, or Protein; Receptor |
- 32. CHOLEDOCHOPLASTY
- [ ] (UMLS (ICD9CM) C0702152) =Therapeutic or Preventive Procedure ;
| - 82. Cholinergic Receptor, Muscarinic 1 Gene
- [This gene is involved in G protein-coupled receptor signal transduction that is elicited by acetylcholine interactions. ( NCI )] (UMLS (NCI) C1332758) CHRM1;
CHRM1 Gene =Gene or Genome ;
|
- 33. cholelith
- [presence or formation of gallstones in the gallbladder. ( CSP )] (UMLS (CSP) C0008350) =Disease or Syndrome ;
=Unspecified disorder of gallbladder;
=Common Bile Duct Calculi | - 83. Cholinergic Receptor, Muscarinic 3
- [The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The muscarinic cholinergic receptor 3 controls smooth muscle contraction and its stimulation causes secretion of glandular tissue. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1334832) CHRM3;
Muscarinic Acetylcholine Receptor M3 =Amino Acid, Peptide, or Protein; Receptor |
- 34. CHOLEPERITONITIS
- [ ] (UMLS (ICD9CM) C1561635) =Disease or Syndrome
| - 84. Cholinergic Receptor, Muscarinic 3 Gene
- [This gene plays a role in the regulation of smooth muscle contraction and glandular tissue secretions. ( NCI )] (UMLS (NCI) C1332759) CHRM3;
CHRM3 Gene =Gene or Genome ;
|
- 35. cholera
- [acute diarrheal disease endemic in India and southeast Asia whose causative agent is Vibrio cholerae; can lead to severe dehydration in a matter of hours unless quickly treated. ( CSP )] (UMLS (CSP) C0008354) =Disease or Syndrome ;
=Vibrio Infections;
Gastrointestinal Infection | - 85. Cholinergic Receptor, Muscarinic 5
- [Muscarinic m5 acetylcholine receptor; affects multiple pathways including phosphatidylinositol metabolism; member of the G protein-coupled receptor family. (Proteome Summary) ( NCI )] (UMLS (NCI) C1334834) CHRM5;
Muscarinic Acetylcholine Receptor M5 =Amino Acid, Peptide, or Protein; Receptor |
- 36. cholera
- [vaccines or candidate vaccines used to prevent infection with Vibrio cholerae. ( CSP )] (UMLS (HL7) C0008359) =Pharmacologic Substance; Immunologic Factor =bacterial vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
| - 86. Cholinergic Receptor, Muscarinic 5 Gene
- [This gene plays a role in G protein-coupled receptor signal transduction, and may play a role in the regulation of cyclic AMP levels. ( NCI )] (UMLS (NCI) C1332761) CHRM5;
CHRM5 Gene =Gene or Genome ;
|
- 37. CHOLERA CONTACT
- [ ] (UMLS (ICD9CM) C0260340) =Finding
| - 87. Cholinergic Receptor, Muscarinic, 4 Gene
- [This gene plays a role in G protein-coupled receptor signal transduction, and may play a role in adenylyl cyclase inhibition. ( NCI )] (UMLS (NCI) C1332760) CHRM4;
CHRM4 Gene =Gene or Genome ;
|
- 38. CHOLERA D/T VIB EL TOR
- [ ] (UMLS (ICD9CM) C0343372) =Disease or Syndrome
| - 88. CHOLINERGIC URTICARIA
- (UMLS (ICD9CM) C0152230) =Disease or Syndrome ;
|
- 39. Cholera Immunization
- (UMLS (HL7) C1548834) =Health Care Activity =Consent Type;
| - 89. cholinesterase inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of cholinesterase resulting in the potentiation of the action of endogenously released acetylcholine at cholinergic synapses; cholinesterase inhibition is associated with a variety of acute symptoms such as nausea, vomiting, blurred vision, stomach cramps, and rapid heart rate. ( CSP )] (UMLS (CSP) C0008425) =Organic Chemical; Pharmacologic Substance ;
=enzyme inhibitor;
esterase inhibitor =DFP;
neostigmine;
PYRIDOSTIGMINE;
tacrine;
|
- 40. cholera toxin
- [enterotoxin from Vibrio cholerae that consists of two major protomers, the heavy (h) or a subunit and the b protomer which consists of 5 light (l) or b subunits. ( CSP )] (UMLS (CSP) C0008356) =Amino Acid, Peptide, or Protein; Enzyme; Hazardous or Poisonous Substance ;
=Enterotoxin;
| - 90. Cholografin
- (UMLS (NCI) C0729199) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 41. CHOLERA VACCINATION
- (UMLS (ICD9CM) C0042199) =Therapeutic or Preventive Procedure ;
| - 91. CHONDRITIS OF PINNA
- [ ] (UMLS (ICD9CM) C0741305) =Pathologic Function
|
- 42. choleretic
- [gastrointestinal agent that stimulates the flow of bile into the duodenum or stimulates the production of bile by the liver. ( CSP )] (UMLS (CSP) C0008362) =Pharmacologic Substance ;
=Drug;
| - 92. Chondroblast
- [A cartilage-forming cell derived from a mesenchymal cell. The chondroblast secretes hyaluronidase, chondroitin sulfates, and collagen II to form a collagen matrix. It differentiates into a chondrocyte. ( NCI )] (UMLS (NCI) C0225368) =Cell
|
- 43. cholestane compound
- [C27 hydrocarbon parent structure for the synthesis of mammalian steroids. ( CSP )] (UMLS (CSP) C0008366) =Steroid ;
=Steroid;
sterol =(-)-Cholesterol;
ergosterol;
lanosterol;
sitosterol;
[VT500] VITAMIN D;
Cholestenes;
sterol | - 93. Chondroblastic Osteogenic Sarcoma
- [An osteosarcoma characterised by the presence of atypical cartilage of variable cellularity. It may or may not be associated with the presence of myxoid areas or focal bone formation. ( NCI )] (UMLS (NCI) C0279603) =Neoplastic Process
|
- 44. cholestanol
- [A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter. ( MSH )] (UMLS (CSP) C0012282) =Steroid; Biologically Active Substance
| - 94. chondroblastoma
- [A benign, lytic neoplasm usually arising from the cartilage in epiphysis and metaphysis of bone. It is a well circumscribed tumor characterized by the presence of chondroblasts, osteoclast-like giant cells, myxoid stroma formation, calcification, and mitotic activity. In aggressive cases, there is rearrangement of the 8q21 chromosome band. The tumor occurs most frequently in children and young adults. ( NCI )] (UMLS (CSP) C0008441) =Neoplastic Process =connective tissue cancer;
|
- 45. Cholestatic Jaundice
- [JAUNDICE, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS. ( MSH )] (UMLS (NCI) C0022354) =Disease or Syndrome ;
| - 95. CHONDROCALC NOS-FOREARM
- [ ] (UMLS (ICD9CM) C0157877) =Disease or Syndrome
|
- 46. cholesteatoma
- [non-neoplastic keratinizing mass with stratified squamous epithelium, frequently occurring in the meninges, central nervous system, bones of the skull, and most commonly in the middle ear and mastoid region. ( CSP )] (UMLS (CSP) C0008373) =Disease or Syndrome ;
=keratosis;
Middle Ear Disorder =CHOLESTEATOMA MIDDLE EAR | - 96. CHONDROCALC NOS-OTH SITE
- [ ] (UMLS (ICD9CM) C0157882) =Disease or Syndrome
|
- 47. CHOLESTEATOMA EXTERN EAR
- [ ] (UMLS (ICD9CM) C0155398) =Disease or Syndrome
| - 97. CHONDROCALCIN NOS-ANKLE
- [ ] (UMLS (ICD9CM) C0157881) =Disease or Syndrome
|
- 48. CHOLESTEATOMA MIDDLE EAR
- [A mass of KERATIN-producing squamous EPITHELIUM that resembles an inverted (suck-in) bag of skin in the MIDDLE EAR. It arises from the eardrum (TYMPANIC MEMBRANE) and grows into the MIDDLE EAR causing erosion of EAR OSSICLES and MASTOID that contains the INNER EAR. ( MSH )] (UMLS (ICD9CM) C0155490) =Disease or Syndrome ;
=cholesteatoma;
DISORDER OF EAR NOS | - 98. CHONDROCALCIN NOS-HAND
- [ ] (UMLS (ICD9CM) C0157878) =Disease or Syndrome
|
- 49. CHOLESTEATOMA OF ATTIC
- (UMLS (ICD9CM) C0155489) =Disease or Syndrome ;
| - 99. CHONDROCALCIN NOS-L/LEG
- [ ] (UMLS (ICD9CM) C0157880) =Disease or Syndrome
|
- 50. Cholesteatoma of middle ear and mastoid
- (UMLS (ICD9CM) C0008374) =Disease or Syndrome ;
| - 100. CHONDROCALCIN NOS-MULT
- [ ] (UMLS (ICD9CM) C0157883) =Disease or Syndrome
|
home
